Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic

Eijkelboom AH, de Munck L, Lobbes MBI, van Gils CH, Wesseling J, Westenend PJ, Guerrero Paez C, Pijnappel RM, Verkooijen HM, Broeders MJM, Siesling S, NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. Prev Med. 2021; 151: 106602.